Hims

(Newser) - In a direct challenge to the booming obesity-drug business, telehealth company Hims & Hers has rolled out what it says is the cheapest GLP-1 weight-loss pill in the US—and it's already rattling Wall Street and one of the industry's biggest players. The online platform is offering compounded...

(Newser) - Shares of Hims & Hers plunged over 30% after Wegovy maker Novo Nordisk abruptly ended their partnership on Monday, accusing the telehealth company of selling unauthorized versions of its popular weight-loss drug. As the Wall Street Journal reports, the split exposes growing tensions between pharmaceutical giants and telehealth firms...

(Newser) - A growing number of young men worried about hair loss are running into serious health trouble after—legally—buying the drug finasteride from telehealth providers, the Wall Street Journal reports. The story includes the accounts of 17 men who describe side effects ranging from sexual dysfunction and insomnia to depression...

(Newser) - Even folks who aren't into football tune into the Super Bowl for its ads, but this year there's some "big drama" around one that's set to air on Sunday, reports Quartz . A pharmaceuticals industry group is slamming a "dangerous" advertisement from Hims & Hers, asking...